Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
life sciences
national blog main
national top stories
new york
3
×
new york blog main
new york top stories
san francisco blog main
boston top stories
clinical trials
san francisco top stories
sanofi
akili interactive labs
allergan
amgen
bristol-myers squibb
bruce leuchter
cholesterol
click therapeutics
clickotine
clinical data
data
david benshoof klein
david klein
digital health
digital medicines
digital therapeutics
fda
genfit
gilead sciences
inclisiran
intercept pharmaceuticals
joshua steinerman
ldl
ldl-c
liver
liver disease
madrigal pharmaceuticals
mark pruzanski
mark timney
What
drug
medicine
3
×
announced
medicines
aces
approved
backs
bets
big
ceo
cholesterol
click
data
digital
disease
example
fatty
field
flexible
gain
grabbed
horizon
inclisiran
intercept
key
known
latest
liver
lowering
makers
making
marketed
meant
medco
momentum
monday
nascent
nasdaq
nash
new
Language
unset
Current search:
" new york "
×
medicine
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum